Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | SLC16A3 | O15427 | 2/20 | 0.37 |
| ▸ | SLC16A1 | P53985 | 2/20 | 0.37 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL360120 | 0.89 | KDM4E (0.42) | KDM4ELMNAATMSLC16A3SLC16A1 | |
| SCHEMBL2400315 | 0.87 | KDM4E (0.41) | KDM4ELMNAATMSLC16A3SLC16A1 | |
| SCHEMBL5580245 | 0.86 | KDM4E (0.40) | KDM4ELMNAATMSLC16A3SLC16A1 | |
| SCHEMBL1274438 | 0.86 | KDM4E (0.40) | KDM4ELMNAATMSLC16A3SLC16A1 | |
| SCHEMBL1275063 | 0.86 | KDM4E (0.40) | KDM4ELMNAATMSLC16A3SLC16A1 | |
| SCHEMBL3245889 | 0.82 | KDM4E (0.35) | KDM4ELMNAATMSLC16A3SLC16A1 | |
| SCHEMBL7563918 | 0.80 | GRIK1 (0.42) | KDM4ELMNAATMSLC16A3SLC16A1 | |
| SCHEMBL15606 | 0.80 | GRIK1 (0.42) | KDM4ELMNAATMSLC16A3SLC16A1 | |
| SCHEMBL15607 | 0.80 | GRIK1 (0.42) | KDM4ELMNAATMSLC16A3SLC16A1 | |
| SCHEMBL5109758 | 0.78 | GRIK1 (0.39) | KDM4ESLC16A3SLC16A1CISD1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3666940-A1 | METHOD OF PRODUCING POLY(ALKYL CYANOACRYLATE) BASED NANO/MICROFIBERS AND USES THEREOF | Charité - Universitätsmedizin Berlin (DE) | 2020-06-17 | — | — | EP | claimed |
| US-9062151-B1 | Protein-cyanoacrylate nanoparticles that improve wetting property of materials | The United States of America, as represented by The Secretary of Agiculture (US) | 2015-06-23 | — | — | US | claimed |
| EP-1455738-B1 | USE OF ELECTROPHILIC MONOMERS FOR HAIR TREATMENT | OREAL (FR) | 2010-07-28 | — | — | EP | claimed |
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | S.N. BIOTECH, INC. | 2002-05-30 | — | — | US | claimed |
| US-3940362-A | Cross-linked cyanoacrylate adhesive compositions | JOHNSON & JOHNSON (US) | 1976-02-24 | — | — | US | claimed |
| WO-2025119862-A1 | COMPOSITION COMPRISING N-HEPTYLCYANOACRYLATE | BOSTIK SA (FR) | 2025-06-12 | — | — | WO | disclosed |
| EP-4567084-A1 | COMPOSITION COMPRISING N-HEPTYLCYANOACRYLATE | Bostik SA (FR) | 2025-06-11 | — | — | EP | disclosed |
| US-20210244023-A1 | COMPOSITIONS CONTAINING MICROENCAPSULATED ORGANIC COMPOUNDS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE | 2021-08-12 | — | — | US | disclosed |
| EP-3666940-A1 | METHOD OF PRODUCING POLY(ALKYL CYANOACRYLATE) BASED NANO/MICROFIBERS AND USES THEREOF | Charité - Universitätsmedizin Berlin (DE) | 2020-06-17 | — | — | EP | disclosed |
| EP-2614096-B1 | ADHESIVE SYSTEM, METHOD OF ASSEMBLY OF DISTINCT COMPONENTS THEREWITH | TEKNOR APEX CO (US) | 2018-12-05 | — | — | EP | disclosed |
| EP-3181567-A1 | PYRAZOLOPYRIMIDINE COMPOUNDS AS KINASE INHIBITORS | PRINCIPIA BIOPHARMA, INC. (US) | 2017-06-21 | — | — | EP | disclosed |
| EP-2366721-B1 | Medical kit for use during negative pressure wound therapy | AESCULAP AG (DE) | 2016-08-10 | — | — | EP | disclosed |
| US-20100035997-A1 | KIT FOR APPLYING A POLYMERIZABLE ADHESIVE COMPOSITION TO TISSUES | BROADLEY KENNETH N | 2010-02-11 | — | — | US | disclosed |
| EP-1360257-B1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | LOCTITE R & D LTD (IE) | 2007-07-25 | — | — | EP | disclosed |
| US-6977278-B1 | Cyanoacrylate compositions curable to flexible polymeric materials | LOCTITE (R&D) LTD. (IE) | 2005-12-20 | — | — | US | disclosed |
| US-6583250-B2 | Particularly to cyanoacrylate adhesives, by mixing in a polymerization initiator capable of initiating polymerization of the monomers of the adhesive, at a temperature above the polyolefin's glass transition temperature | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2003-06-24 | — | — | US | disclosed |
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | S.N. BIOTECH, INC. | 2002-05-30 | — | — | US | disclosed |
| US-20010009954-A1 | POLYOLEFINE MATERIALS WITH IMPROVED ADHESIVITY | COGNIS DEUTSCHLAND GMBH & CO. KG (DE) | 2001-07-26 | — | — | US | disclosed |
| US-5767152-A | USING A CYANOCARBOXYLIC ACID | S.N. BIOTECH, INC. | 1998-06-16 | — | — | US | disclosed |
| US-3940362-A | Cross-linked cyanoacrylate adhesive compositions | JOHNSON & JOHNSON (US) | 1976-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100035997-A1 | KIT FOR APPLYING A POLYMERIZABLE ADHESIVE COMPOSITION TO TISSUES | KIT, TEKT1, CUTA | KDM4E 2358/4885LMNA 3618/4885ATM 1385/4885 |
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | AREG, NGF, HDGF | KDM4E 4496/4885LMNA 3582/4885ATM 4360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.